Related Experiment Video
Updated: Jun 21, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
Pharmacotherapy of lower urinary tract infections and pyelonephritis in children
1Service de Néphrologie Pédiatrique, Hôpital d'Enfants Armand Trousseau (APHP), 75012 Paris, France.
Insights
This review distinguishes urinary tract infections (UTIs) in children, emphasizing prompt antibiotic treatment for pyelonephritis and cystitis. Asymptomatic bacteriuria requires exceptional antibiotic use due to potential harm and resistance risks.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Pharmacology
Background:
- Urinary tract infections (UTIs) in children encompass acute pyelonephritis, acute cystitis, and asymptomatic bacteriuria.
- Distinguishing these conditions is crucial for appropriate management.
- Asymptomatic bacteriuria may not require antibiotics and carries risks of harm and bacterial resistance.
Purpose of the Study:
- To review current treatment strategies for pediatric UTIs.
- To highlight the importance of differentiating UTI subtypes.
- To inform clinical practice regarding antibiotic use in children with UTIs.
Main Methods:
- Literature review of pediatric UTI treatment guidelines and research.
- Analysis of diagnostic criteria for pyelonephritis, cystitis, and asymptomatic bacteriuria.
- Evaluation of antibiotic efficacy and risks in different UTI presentations.
Main Results:
- Antibiotics are essential for treating acute pyelonephritis and acute cystitis.
- Antibiotic use for asymptomatic bacteriuria should be exceptional due to potential adverse effects.
- Early treatment of pyelonephritis is critical to prevent long-term renal complications like scarring.
Conclusions:
- Accurate diagnosis and differentiation of pediatric UTIs are paramount for effective treatment.
- Antibiotic stewardship is vital, particularly in cases of asymptomatic bacteriuria.
- Treatment guidelines must be updated regularly based on local resistance patterns and healthcare economics.
Abstract:
This review focuses on the treatment of urinary tract infections (UTI) in children. Acute pyelonephritis (an infection involving the renal parenchyma), acute cystitis (infection limited to the lower urinary tract) and asymptomatic bacteriuria (absence of clinical symptoms) have to be clearly distinguished. Whereas antibiotics are needed in pyelonephritis and cystitis, they should be used only exceptionally in cases of asymptomatic bacteriuria, as they may be potentially harmful and select more virulent bacteria. In case of pyelonephritis, there should be no delay in beginning the treatment in order to decrease the risk of long term complication in particular renal scars. Predisposing conditions for UTI should be evaluated carefully. New concepts concerning analysis of virulence profile or specific host immune response might bring more comprehension to UTI, but yet these concepts do not influence clinical practice. Any recommendation about (initial) antibiotic treatment should be regularly updated and adapted to local resistance profiles and to economical factors in different health systems.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection IV: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis I: Introduction
Urinary Tract Infection I: Introduction